Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 par value per share
-
Shares outstanding
-
73.8M
-
Number of holders
-
90
-
Total 13F shares, excl. options
-
14.3M
-
Shares change
-
+913K
-
Total reported value, excl. options
-
$66.5M
-
Value change
-
+$4.42M
-
Put/Call ratio
-
0.9
-
Number of buys
-
37
-
Number of sells
-
-32
-
Price
-
$4.65
Significant Holders of RELMADA THERAPEUTICS, INC. - Common Stock, par value $0.001 par value per share (RLMD) as of Q1 2024
104 filings reported holding RLMD - RELMADA THERAPEUTICS, INC. - Common Stock, par value $0.001 par value per share as of Q1 2024.
RELMADA THERAPEUTICS, INC. - Common Stock, par value $0.001 par value per share (RLMD) has 90 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14.3M shares
of 73.8M outstanding shares and own 19.37% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (1.26M shares), Deep Track Capital, LP (1.24M shares), Vestal Point Capital, LP (1.2M shares), ACADIAN ASSET MANAGEMENT LLC (1.18M shares), PARSONS CAPITAL MANAGEMENT INC/RI (974K shares), Opaleye Management Inc. (759K shares), Palo Alto Investors LP (732K shares), FRANKLIN RESOURCES INC (630K shares), BlackRock Inc. (578K shares), and MILLENNIUM MANAGEMENT LLC (341K shares).
This table shows the top 90 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.